Table 1.
Characteristics of patient cohort.
| Gender [n (%)] | Male | 67 (72.0) | ||
| Female | 26 (28.0) | |||
| Age [years] | Median | 61 | ||
| Min. | 18 | |||
| Max. | 92 | |||
| Underlying condition [n (%)] | ||||
| Haematological malignancy | 70 (75.3) | |||
| Acute leukemias | ||||
| • AML | 25 (26.9) | |||
| • ALL | 7 (7.5) | |||
| MDS | 8 (8.6) | |||
| Chronic leukemias | ||||
| • CLL | 1 (1.1) | |||
| • MM | 7 (7.5) | |||
| Myeloproliferative diseases | ||||
| • CML | 6 (6.5) | |||
| • MPS | 6 (6.5) | |||
| Lymphoma | ||||
| • HD | 2 (2.2) | |||
| • NHL | 6 (6.5) | |||
| Aplastic anaemia | 2 (2.2) | |||
| Allogenic stem cell transplantation [n (% of haematological malignancy)] | 41 (58.6) | |||
| Solid Cancer | 20 (21.5) | |||
| Lung (SCLC/NSCLC) | 7 (7.5) | |||
| Intestine | 5 (5.4) | |||
| Mouth | 4 (4.3) | |||
| Bladder | 1 (1.1) | |||
| Sarcoma | 1 (1.1) | |||
| Testis | 1 (1.1) | |||
| Breast | 1 (1.1) | |||
| Organ transplantation | 1 (1.1) | |||
| Kidney | 1 (1.1) | |||
| Other | 2 (2.2) | |||
| EORTC/MSG | Probable | Possible | Not categorisable | Total |
| Samples [n] | 11 | 51 | 41 | 103 |
| Patients [n] | 10 | 46 | 37 | 93 |
Abbreviations: AML, acute myeloma leukaemia; ALL, acute lymphatic leukaemia; MDS, myelodysplastic syndrome; CLL, chronic lymphocytic leukaemia; MM, multiple myeloma; CML, chronic myeloid leukaemia; MPS, myeloproliferative syndromes; HD, Hodgkin’s lymphoma; NHL, non-Hodgkin lymphoma; SCLC, Small Cell Lung Cancer; NSCLC, Non-Small Cell Lung Cancer.